Wesley Tong
6PUBLICATIONS
38CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Aug 31, 2025
Cost-effectiveness of apixaban vs. aspirin for the reduction of thrombo-embolism in high-risk patients with device-detected atrial fibrillation: insights from the ARTESiA trial.Andre Lamy, Roopinder K Sandhu, Wesley Tong
|May 15, 2023
Cost Implications of Left Atrial Appendage Occlusion During Cardiac Surgery: A Cost Analysis of the LAAOS III Trial.Adam Eqbal, Wesley Tong, Andre Lamy
|Nov 05, 2022
The impact of statistical properties of incremental monetary net benefit and incremental cost-effectiveness ratio on health economic modeling choices.Fei Yuan, Shrikant I Bangdiwala, Wesley Tong
|Dec 28, 2021
The cost implications of a polypill for primary prevention in the TIPS-3 trial.Andre Lamy, Wesley Tong, Philip Joseph
|Jul 26, 2021
The Cost Implications of Dabigatran in Patients with Myocardial Injury After Non-Cardiac Surgery.Andre Lamy, Wesley Tong, Rajibul Mian
|Aug 04, 2020
Projecting effectiveness after ending a randomized controlled trial: a two-state Markov microsimulation model.Fei Yuan, Shrikant I Bangdiwala, Wesley Tong
Pageof 1
Frequent Collaborators
5 joint publications
Andre Lamy
2 joint publications
Fei Yuan
2 joint publications
Shrikant I Bangdiwala
1 joint publications
Wojciech Szczeklik
1 joint publications
Prem Pais
1 joint publications
Patricio Lopez-Jaramillo
1 joint publications
Marjan Walli-Attaei
1 joint publications
Antonio L Dans
1 joint publications
Anwar Santoso
1 joint publications
Habib Gamra
